Pharmaceutical compositions containing one or more lymphocyte growth factors
US4720482A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jun 5, 1986 |
| Grant date | Jan 19, 1988 |
| Priority date | — |
| Expiry date | Jun 5, 2006 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a pharmaceutical composition, comprising a mammalian cell growth factor and a pharmaceutically acceptable carrier. The growth factor of the present invention is selected from the group comprising; PA1 (a) a protein having a molecular weight of about 14 kilodaltons and being functional to stimulate growth of both B and T lymphocytes; PA1 (b) a protein having an apparent molecular weight of about 50 kilodaltons and being functional to stimulate growth of B lymphocytes; and PA1 (c) a growth factor having an apparent mean molecular weight of about 45 kilodaltons and being funtional to stimulate growth of mast cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.